您使用提示模式 关闭
为了方块之间的快速移动

组织机构: Sanofi
LEI 549300E9PC51EN656011, Swift码 SAAVFRPPXXX

机构名称
Sanofi SA
国家名称
法国
注册登记国
法国
行业
药品生产和生物技术
债券负债
15.403 百万 USD

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件
请求访问

最新数据在

卖价

查询已发送
无法访问
发送查询
信息提供者所提供的报价仅供参考。

简介

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health. Sanofi has a portfolio of prescription drugs, vaccines, generics and consumer healthcare products. In December 2011, Sanofi announced that it completed the divestiture of its dermatology business, Dermik, to Valeant Pharmaceuticals International, Inc. The Company is active domestically and abroad, including other European countries, North and Latin Americas, Asia, Africa and Middle East. As of January 31, 2012, the Companys major shareholder was Loreal with a stake of 8.82%.

奖项

新闻

2024-03-28 Moody's Investors Service revised outlook on Sanofi to positive and affirmed at "A1" (LT- local currency) credit rating
2024-03-28 Moody's Investors Service revised outlook on Sanofi to positive and affirmed at "A1" (LT- foreign currency) credit rating
2023-12-15 Fitch Ratings withdrew LT Int. Scale (foreign curr.) credit rating for Sanofi
2023-12-14 Fitch Affirms Sanofi at 'AA-'/ Stable; Withdraws All Ratings (Rating action commentary)
2023-05-22 Fitch Ratings upgrades LT Int. Scale (foreign curr.) credit rating of Sanofi to "AA-" from "A+"; outlook stable
所有机构分析

相关文件

IFRS / US GAAP 财务报告

2023
II q 英语
IV q 英语
2022
II q 英语
IV q 英语
2021
II q 英语
IV q 英语
2020
II q 英语
IV q 英语
2019
II q 英语
IV q 英语
2018
II q 英语
IV q 英语
2017
IV q 英语
显示全部 隐藏
请求认证
需要 访问

股票

最近一次的发行

全部显示

债券负债 (按货币)

显示所有 隐藏

代码

  • LEI
    549300E9PC51EN656011
  • Swift码
    SAAVFRPPXXX
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • ICB
    4.500 Health Care
  • CIK
    0001121404
  • EIN
    13-3529324

信用和 ESG 评级

宏观经济指数

你必须 注册 才能获得访问权